OrigiMed (Shanghai) Co., Ltd., (OrigiMed) has formally announced the completion of its Series B financing.
On September 21, 2018, the CSCO precision medicine international session with the theme of "All-Round Research by Experts for Further Study", hosted by the Chinese Society of Clinical Oncology (CSCO) and organized solely by OrigiMed Co., Ltd.
OrigiMed announces an agreement with Illumina in Shanghai, China. It will develop and promote its advanced molecular clinical tumor applications to the public based on the Next Generation Sequencing (NGS) technology of Illumina.
5th Floor, Building 3, 115 Xinjun Ring Road, Minhang District, Shanghai
Floor 4, Information Building 2, Zhaolou Road 3576 , Pujiang Town, Minhang District, Shanghai
Service Hours：9:00-18:00 Monday to Friday (except statutory holidays)
We will reply you as soon as we receive the email.
All rights reserved in © Copyright 2022 OrigiMed Ltd